NASDAQ : ICU

SeaStar Medical Holding Corporation — Financial statements

Healthcare · Biotechnology · United States

Last price 2.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.15M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

SeaStar Medical Holding Corporation (ICU) reported revenue of 1.71M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue1.71M1.23M135.00K
Cost of Revenue126.00K53.00K
Gross Profit1.59M1.18M135.00K
Selling, General & Admin6.66M5.84M8.87M8.04M6.92M1.68M
Research & Development8.91M7.52M9.11M5.97M2.50M2.77M
Other Operating Expenses2.19M
Operating Expenses15.58M13.36M17.98M14.01M11.61M4.45M
Operating Income-13.99M-12.18M-17.84M-14.01M-11.61M-4.45M
Interest Expense-27.00K-31.00K-244.00K-1.08M-630.00K-212.00K
Interest & Investment Income392.00K325.00K101.00K
Other Non Operating Income (Expenses)-266.00K-6.84M-5.99M50.00K64.00K
EBT Excluding Unusual Items-13.62M-12.15M-24.83M-21.08M-12.19M-4.60M
Legal Settlements-200.00K
Other Unusual Items-4.95M
Pretax Income-13.62M-12.15M-24.83M-26.23M-12.19M-4.60M
Income Tax Expense3.00K3.00K3.00K1.00K-1.00K
Net Income-13.63M-12.15M-24.83M-26.23M-12.19M-4.60M
Net Income to Common-13.63M-12.15M-24.83M-26.23M-12.19M-4.60M
Shares Outstanding (Basic)3.57M2.07M374.36K86.68K32.84K28.95K
Shares Outstanding (Diluted)3.57M2.07M374.36K86.68K32.84K28.95K
EPS (Basic)-3.81-5.86-66.33-302.63-371.14-158.73
EPS (Diluted)-3.81-5.86-66.33-302.63-371.14-158.73
Gross Margin92.64%95.70%100.00%
Operating Margin-816.64%-986.63%-13,216.30%
Profit Margin-795.50%-984.60%-18,392.59%
EBIT-13.99M-12.18M-17.84M-14.01M-11.61M-4.45M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents6.96M11.98M1.82M176.00K47.00K510.00K
Cash & Short-Term Investments6.96M11.98M1.82M176.00K47.00K510.00K
Accounts Receivable208.00K237.00K112.00K
Other Receivables12.00K58.00K
Receivables208.00K237.00K112.00K12.00K58.00K
Inventory77.00K66.00K
Prepaid Expenses984.00K1.30M1.83M2.13M1.46M33.00K
Total Current Assets8.23M13.58M3.77M2.31M1.52M601.00K
Other Long-Term Assets421.00K578.00K892.00K1.21M1.52M2.00K
Total Assets8.65M14.16M4.66M3.51M3.04M603.00K
Accounts Payable750.00K948.00K3.05M4.37M1.93M85.00K
Accrued Expenses3.47M2.27M3.19M1.52M2.25M186.00K
Short-Term Debt134.00K525.00K574.00K565.00K910.00K
Current Portion of Long-Term Debt4.18M268.00K2.38M
Current Unearned Revenue100.00K
Other Current Liabilities1.00K1.00K33.00K2.31M10.80M471.00K
Total Current Liabilities4.35M3.74M6.84M13.05M16.15M3.12M
Long-Term Debt4.34M7.65M244.00K
Other Long-Term Liabilities55.00K
Total Liabilities4.35M3.74M6.84M17.38M23.80M3.42M
Common Stock4.00K4.00K2.00K1.00K1.00K1.00K
Additional Paid-In Capital163.26M162.13M137.38M100.86M67.74M73.50M
Retained Earnings-158.97M-151.71M-139.56M-114.73M-88.50M-76.31M
Total Common Equity4.30M10.42M-2.18M-13.87M-20.76M-2.82M
Shareholders' Equity4.30M10.42M-2.18M-13.87M-20.76M-2.82M
Total Liabilities & Equity8.65M14.16M4.66M3.51M3.04M603.00K
Total Debt134.00K525.00K574.00K9.08M8.83M2.62M
Net Cash (Debt)6.83M11.46M1.25M-8.90M-8.78M-2.11M
Net Cash Per Share1.915.533.33-102.73-267.41-72.94
Filing Date Shares Outstanding4.41M3.99M872.10K301.68K53.19K28.95K
Total Common Shares Outstanding4.26M3.84M597.73K190.46K50.80K28.95K
Working Capital3.88M9.84M-3.08M-10.74M-14.63M-2.52M
Book Value Per Share1.012.71-3.65-72.82-408.71-97.25
Tangible Book Value4.30M10.42M-2.18M-13.87M-20.76M-2.82M
Tangible Book Value Per Share1.012.71-3.65-72.82-408.71-97.25

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-13.63M-12.15M-24.83M-26.23M-12.19M-4.60M
Other Amortization14.00K18.00K102.00K48.00K242.00K
Stock-Based Compensation352.00K922.00K887.00K1.93M1.31M14.00K
Other Operating Activities-32.00K6.84M11.09M291.00K148.00K
Change in Accounts Receivable9.00K-125.00K-112.00K12.00K4.00K
Change in Inventory-66.00K55.00K
Change in Accounts Payable-2.41M-2.10M-1.28M2.44M1.55M-297.00K
Change in Other Net Operating Assets1.97M-68.00K2.38M420.00K1.00M-438.00K
Operating Cash Flow-13.69M-13.60M-16.01M-10.29M-7.79M-5.11M
Short-Term Debt Issued767.00K713.00K
Long-Term Debt Issued979.00K8.80M20.52M2.84M
Total Debt Issued767.00K767.00K1.69M8.80M20.52M2.84M
Short-Term Debt Repaid-834.00K-5.40M
Long-Term Debt Repaid-700.00K-5.27M-78.00K-20.00K
Total Debt Repaid-647.00K-834.00K-6.10M-5.27M-78.00K-20.00K
Net Debt Issued (Repaid)120.00K-67.00K-4.41M3.53M20.44M2.82M
Issuance of Common Stock13.92M17.94M18.29M5.51M
Other Financing Activities306.00K5.89M3.77M1.37M-13.11M
Financing Cash Flow14.35M23.76M17.65M10.41M7.33M2.82M
Net Cash Flow657.00K10.16M1.64M129.00K-463.00K-2.30M
Levered Free Cash Flow-9.14M-9.39M-12.16M-14.78M6.75M-3.21M
Unlevered Free Cash Flow-9.14M-9.39M-12.11M-14.15M6.90M-3.08M
Cash Interest Paid553.00K1.13M6.00K
Cash Income Tax Paid3.00K3.00K3.00K1.00K
Change in Working Capital-432.00K-2.36M992.00K2.88M2.55M-680.00K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization11.99M8.65M8.66M19.70M52.07M
Enterprise Value5.17M-5.11M6.58M29.75M130.24M
Last Close Price2.242.4019.40110.671,025.002,509.97
PS Ratio6.887.0164.14
PB Ratio2.220.83-3.97-1.42-2.51
P/TBV Ratio2.740.83
EV/Sales Ratio2.9048.72
Debt / Equity Ratio0.030.05-0.26-0.66-0.42-0.93
Net Debt / Equity Ratio-1.59-1.100.57-0.64-0.42-0.75
Asset Turnover0.200.130.03
Quick Ratio1.653.270.280.010.000.18
Current Ratio1.893.630.550.180.090.19
Return on Equity (ROE)-356.87%-295.15%
Return on Assets (ROA)-102.67%-80.88%-272.95%-267.32%-398.55%-158.35%
Return on Capital Employed (ROCE)-325.60%-116.90%817.30%147.00%88.60%176.80%
Earnings Yield-167.19%-140.44%-286.77%-133.16%-23.41%
Buyback Yield / Dilution-393.33%-453.77%-331.88%-163.91%-13.44%